Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial - Li, J; Qin, S; Xu, R; Yau, TC; Ma, B; Pan, H (Lancet Oncol, 2015)